In his lab at Baylor College of Medicine, Dr. Sean M. Hartig and his colleagues investigate novel ways to control obesity and type 2 diabetes by studying the cellular and molecular mechanisms involved in fat metabolism using both genetic mouse models and human tissues.
“We are interested in this idea that we can uncouple obesity from co-morbidities such as heart disease and insulin resistance,” Hartig said. “It has become clear in the past 10 years that obesity doesn’t always mean diabetes. We are interested in learning how to manipulate the inflammatory response inside fat tissue of people with insulin resistance or type 2 diabetes so they expand the subcutaneous white fat deposits and become metabolically healthy.” Read the complete story here.
Find out all the details about this study in the journal Diabetes.